- ►annals.org [PDF] C Cordonnier, S Chevret, M Legrand, H Rafi, … - Annals of internal medicine, 2003 - Am Coll Physicians Background: The universal use of prophylactic immunoglobulin in stem-cell
transplantation has not been supported by strong evidence of benefit. Results of
most trials were reported before effective drugs for cytomegalovirus ... Cited by 52 - Related articles - BL Direct - All 5 versions
DJ Winston, JH Antin, SN Wolff, BE Bierer, T … - Bone marrow transplantation, 2001 - ncbi.nlm.nih.gov Intravenous immunoglobulin is approved for use in allogeneic bone marrow
transplant recipients for prevention of graft-versus-host disease (GVHD) and
infections, but the minimally effective dose has not been established. In ... Cited by 40 - Related articles - BL Direct - All 3 versions
[CITATION] Antimicrobial prophylaxis in EBMT centers: A report from the EBMT Infectious Working Party
HM Just, M Metzger, W Vogel, RB Pelka - Journal of Molecular Medicine, 1986 - Springer Summary. A randomized controlled clinical trial was conducted on the effects of
immunoglobulin in therapy for infections in 104 intensive care pa- tients. At
the first sign of infection, one group of 50 patients received an iv ... Cited by 17 - Related articles
HG Kress, C Scheidewig, H Schmidt, R Silber - Critical care medicine, 1999 - journals.lww.com From the Institut fur Anaesthesiologie (Dr. Kress and Mr. Scheidewig), the
Institut fur Hygiene und Mikrobiologie (Dr. Schmidt), and the Klinik und
Poliklinik fur Herz- und Thoraxchirurgie (Dr. Silber), Universitat ... Cited by 44 - Related articles - BL Direct - All 4 versions
K Werdan - Therapeutic Apheresis, 2001 - interscience.wiley.com Abstract: The pathophysiology of sepsis and septic shock is dominated by an
imbalance of pro- and antiinflammatory mediators produced by toxin-activated
inflammatory cells. Both the overshooting of proinflammatory mediators as ... Cited by 38 - Related articles - BL Direct - All 3 versions
